Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
作者
4 / 6 观点
COVID-19: Private equity investors and investor directors – dealing with distress
IP, divestments, fragmentation and the future: M&A in life sciences
作者 Emma Danks
Autumn Budget 2018: additional requirements introduced and holding period extended for Entrepreneurs' Relief
Corporate governance reforms and the impact for portfolio companies in 2018